February 14, 2014
1 min read

Bausch + Lomb launches IOL injector system in US

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Bausch + Lomb has launched BLIS, an injector system for the enVista glistening-free hydrophobic acrylic IOL, in the United States, according to a press release.

BLIS, which stands for Bausch + Lomb Injector System, comes with a reusable hand piece and a single-use cartridge, which will allow surgeons to perform safe, controlled delivery of the enVista IOL through unenlarged phaco incisions as small as 2.2 mm, the release said.

BLIS received Health Canada approval in August 2013 and CE mark approval in October 2013, the release said. Additional approvals are pending.